Known primarily for its oncogenic role in breast cancer, overexpression of HER2 has also been found in ∼20% of gastric cancers, as well as cancers of the colon, bladder, endometrium, ovaries, and head and neck, amongst others [7,22]. Here, ERBB2 is linked to gastric cancer.